Does adenomyomectomy preserve fertility in women of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Does Adenomyomectomy Preserve Fertility?

Yes, adenomyomectomy can preserve and improve fertility in carefully selected women with severe adenomyosis, with pregnancy rates of 30-54.5% reported in prospective studies, though the procedure carries significant risks including uterine rupture during pregnancy and requires highly experienced surgeons. 1, 2

Evidence for Fertility Preservation

The strongest recent evidence comes from prospective clinical trials demonstrating that fertility-preserving adenomyomectomy achieves meaningful reproductive outcomes:

  • In a 2023 prospective trial of 45 infertile women with severe diffuse adenomyosis, 54.5% (18/33) of those attempting pregnancy conceived after adenomyomectomy, with 30.3% (10/33) achieving viable pregnancies. 1

  • A 2014 prospective study of 103 women with severe adenomyosis showed that 30% of the 70 patients attempting pregnancy (either naturally or via assisted reproduction) achieved clinical pregnancy, with 16 reaching full-term live birth. 2

  • Both studies demonstrated significant improvement in dysmenorrhea and menorrhagia symptoms post-operatively, with numeric rating scale scores dropping from 7.28 to 1.56 (p<0.001) and menstrual blood loss decreasing from 140.44 mL to 66.33 mL (p<0.05). 1

Patient Selection Criteria

Not all women with adenomyosis are appropriate candidates for adenomyomectomy:

  • The procedure is most appropriate for women with severe, symptomatic adenomyosis who have failed medical management and desire fertility preservation. 3, 4

  • Women presenting with infertility (55.34%), IVF failure (16.50%), recurrent abortion (8.74%), or abnormal uterine bleeding (19.42%) represent the typical candidate profile. 2

  • The procedure should be reserved for focal or nodular adenomyosis when possible, as diffuse adenomyosis involving the entire uterus makes complete excision nearly impossible. 3, 4

Surgical Technique Considerations

The technical approach significantly impacts outcomes:

  • The most successful technique involves T- or transverse H-incision of the uterine serosa, preparation of a serosal flap, excision of adenomyotic tissue (ideally with ultrasound guidance), and specialized suturing between residual myometrium and the serosal flap. 1

  • Alternative approaches include wedge-shaped removal with thin (≤0.5 cm) margins after sagittal incision, with careful layer reconstruction using inverted sutures for the serosal layer. 2

  • The procedure is technically demanding and requires surgeons with extensive experience in complex uterine reconstruction to minimize complications. 5

Critical Risks and Limitations

Several important caveats must be discussed with patients:

  • Spontaneous uterine rupture during subsequent pregnancy is a significant risk, as the procedure involves deep myometrial excision and reconstruction. 5, 2

  • Complete removal of all adenomyotic tissue is often impossible because adenomyosis typically involves the myometrium diffusely, making this a "debulking" or "cytoreductive" procedure rather than curative surgery. 3, 4

  • Recurrence rates remain a concern, though one study reported only 1/103 patients (0.97%) with relapsed adenomyosis during follow-up. 2

  • Miscarriage rates remain elevated even after surgery, with 8/18 pregnancies (44%) ending in miscarriage in one series. 1

  • Adhesion formation is a recognized complication that may further compromise fertility. 2

Alternative Fertility-Preserving Options

When adenomyomectomy is not feasible or desired:

  • Uterine artery embolization (UAE) provides 94% short-term and 85% long-term symptom improvement in women with adenomyosis, though comprehensive fertility data remain limited. 6

  • Medical management with levonorgestrel-releasing IUDs or GnRH antagonists provides temporary symptom relief but does not cure the disease or improve fertility outcomes. 6

  • Combined oral contraceptives reduce bleeding and pain but are less effective than hormonal IUDs and should not be used in women actively attempting conception. 6

Post-Operative Management

After adenomyomectomy, specific protocols are essential:

  • Patients should be counseled that attempting pregnancy via assisted reproductive technology (IVF-ET or frozen embryo transfer) may be necessary, as 49/70 (70%) of pregnancies in one series required ART. 2

  • Close obstetric monitoring during pregnancy is mandatory due to uterine rupture risk, with delivery planning requiring high-risk obstetric consultation. 5

  • Regular follow-up with ultrasound monitoring is needed to detect adenomyosis recurrence, which can occur despite initially successful surgery. 4

When to Avoid Adenomyomectomy

Certain clinical scenarios make adenomyomectomy inappropriate:

  • Women who have completed childbearing should undergo hysterectomy rather than adenomyomectomy, as hysterectomy provides definitive treatment with approximately 90% patient satisfaction. 6

  • Diffuse adenomyosis involving the entire uterus without focal lesions makes complete excision impossible and significantly reduces success rates. 3, 4

  • Patients unable to accept the risks of uterine rupture, recurrence, and potential need for emergency hysterectomy during pregnancy should consider alternative options. 5

Related Questions

What is the best treatment approach for a woman with adenomyosis, an enlarged uterus equivalent to an 18-week pregnancy, who is experiencing heavy menstrual bleeding and pain, and wants to preserve fertility?
Can adenomyomectomy be offered to a reproductive‑age woman with symptomatic adenomyosis who wishes to preserve fertility?
What are the treatment options for adenomyosis versus adenomyoma?
What are the next steps for a patient diagnosed with adenomyosis on ultrasound?
What is the recommended management for a woman with adenomyosis who wishes to become pregnant?
What musculoskeletal conditions can cause a heavy‑or‑rock‑like neck pain that worsens with upright posture (standing or walking) and improves with sitting or lying down, and what initial evaluation and treatment should be pursued?
Why is high water intake recommended in autosomal dominant polycystic kidney disease?
In a patient with type 2 diabetes, when is C‑peptide testing indicated and how should the results be interpreted to guide therapy decisions?
In an elderly, frail patient with poor oral intake and possible renal insufficiency who is taking potassium‑sparing agents (ACE inhibitor [angiotensin‑converting enzyme inhibitor], ARB [angiotensin II receptor blocker], spironolactone), does poor oral intake cause hyperkalemia?
Can adenomyomectomy be offered to a reproductive‑age woman with symptomatic adenomyosis who wishes to preserve fertility?
According to KDIGO, what are the target intact parathyroid hormone levels for each chronic kidney disease stage based on estimated glomerular filtration rate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.